Celltrion, Inc. Stock
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 178,200.00 KRW | +1.31% |
|
-0.56% | +3.38% |
| 07-07 | Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA | MT |
| 07-03 | South Korean Shares Jump on Bargain-Hunting, Chip Stock Gains | MT |
| Market Cap | 40,866B 26.98B 23.61B 21.76B 20.17B 38.28B 2,560B 38.9B 261B 101B 1,264B 101B 99.09B 4,368B | P/E 2026 * |
27.6x | P/E 2027 * | 24.4x |
|---|---|---|---|---|---|
| Enterprise Value | 43.05B 28.42M 24.87M 22.92M 21.24M 40.33M 2.7B 40.98M 275M 107M 1.33B 107M 104M 4.6B | EV / Sales 2026 * |
7.94x | EV / Sales 2027 * | 6.84x |
| Free-Float |
58.37% | Yield 2026 * |
0.41% | Yield 2027 * | 0.45% |
| 1 day | +1.31% | ||
| 1 week | -0.56% | ||
| Current month | +2.83% | ||
| 1 month | +3.97% | ||
| 3 months | -4.44% | ||
| 6 months | -12.15% | ||
| Current year | +3.38% |
| 1 week | 169,000 |  | 188,000 |
| 1 month | 158,500 | | 188,000 |
| Current year | 158,500 | | 239,047.62 |
| 1 year | 158,500 | | 239,047.62 |
| 3 years | 114,250.83 | | 239,047.62 |
| 5 years | 114,250.83 | | 247,058.06 |
| 10 years | 64,487.59 | | 325,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 20/03/2015 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 26/03/2021 |
Hyeok-Jae Lee
PSD | President | 50 | 13/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 01/04/2005 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-16 | Sell | 500 | 0.0002% | |||
| 01-16 | Sell | 1,000 | 0.0004% | |||
| 01-16 | Sell | 1,000 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.31% | -0.56% | +5.12% | +33.90% | 26.98B | |
| -0.42% | +4.43% | +2.15% | +8.57% | 49.74B | |
| +0.25% | +1.70% | +419.39% | +621.71% | 40.49B | |
| -0.16% | +8.42% | +28.20% | +63.00% | 34.35B | |
| +1.10% | +7.77% | +28.18% | -3.96% | 34.75B | |
| -0.35% | +0.09% | - | - | 16.58B | |
| -3.33% | +3.15% | +71.30% | +131.94% | 15.6B | |
| +3.79% | +8.88% | +106.63% | +106.63% | 14.27B | |
| -2.64% | -1.99% | +12.43% | +17.84% | 13.76B | |
| -1.30% | -2.87% | +14.32% | -28.64% | 12.92B | |
| Average | -0.18% | +3.50% | +76.41% | +105.67% | 25.95B | |
| Weighted average by Cap. | -0.00% | +4.21% | +91.26% | +131.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,425B 3.58B 3.13B 2.89B 2.68B 5.08B 340B 5.16B 34.63B 13.47B 168B 13.45B 13.15B 580B | 6,180B 4.08B 3.57B 3.29B 3.05B 5.79B 387B 5.88B 39.45B 15.34B 191B 15.32B 14.98B 660B |
| Net income | 1,518B 1B 877M 808M 749M 1.42B 95.09B 1.44B 9.69B 3.77B 46.93B 3.76B 3.68B 162B | 1,698B 1.12B 981M 904M 838M 1.59B 106B 1.62B 10.84B 4.22B 52.51B 4.21B 4.12B 181B |
| Net Debt | 2,182B 1.44B 1.26B 1.16B 1.08B 2.04B 137B 2.08B 13.93B 5.42B 67.46B 5.41B 5.29B 233B | 1,428B 943M 825M 760M 705M 1.34B 89.47B 1.36B 9.12B 3.55B 44.15B 3.54B 3.46B 153B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | ₩178,200.00 | +1.31% | 624,179 |
| 06/07/26 | ₩175,900.00 | -4.19% | 527,031 |
| 03/07/26 | ₩183,600.00 | +3.96% | 853,838 |
| 02/07/26 | ₩176,600.00 | +1.20% | 712,765 |
| 01/07/26 | ₩174,500.00 | +0.69% | 473,079 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A068270 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
